Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and Formulations
Martina Penazzato(World Health Organization), Marissa Vicari(International AIDS Society), Yodit Belew, David M. Burger(Radboud University Nijmegen), Helen McIlleron, Devasena Gnanashanmugam(Johns Hopkins University), Diana F. Clarke(Boston Medical Center), Diana M. Gibb(Médecins Sans Frontières), Kelsey Mirkovic, Carlo Giaquinto(University of Padua), Chewe Luo(University of North Carolina at Chapel Hill), Atieno Ojoo, Pablo Rojo(Research Institute Hospital 12 de Octubre), Nandita Sugandhi(ICAP Global Health), Paolo Denti, Elaine J. Abrams(ICAP Global Health), Agnès Saint-Raymond, Jessica Burry, Linda Lewis, Nathan Ford(World Health Organization), Natella Rakhmanina(Elizabeth Glaser Pediatric AIDS Foundation), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Janice Lee(Harvard University), Marc Lallemant(Drugs for Neglected Diseases Initiative), Jorge Pinto(Universidade Federal de Minas Gerais), Mark Mirochnick(Boston University), Francesca Rocchi, Rohan Hazra, Tim R. Cressey
Cited by 36
Related Papers
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
|The Lancet|2022|16k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697